NANOVIBRONIX, INC. _______ Units, each consisting of One Share of Common Stock, $0.001 par value and One Warrant to Purchase One Share of Common Stock, $0.001 par value FORM OF UNDERWRITING AGREEMENTNanoVibronix, Inc. • May 12th, 2014 • Orthopedic, prosthetic & surgical appliances & supplies • New York
Company FiledMay 12th, 2014 Industry JurisdictionNanoVibronix, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the several underwriters (the “Underwriters”) named on Schedule I hereto for whom you are acting as representative (the “Representative”), an aggregate of [___________] units (the “Underwritten Units”) of the Company’s securities. The Company has granted the Underwriters the option to purchase an aggregate of up to ___________ additional units (the “Additional Units” and collectively with the Underwritten Units, the “Units”) as may be necessary to cover over-allotments made in connection with the offering. Each Unit consists of one share of the Company’s common stock, par value $0.001 per share (the “Common Stock”), and one warrant (each, a “Warrant” and collectively, the “Warrants”). Each Warrant entitles the holder to purchase one share of Common Stock. The Units, the shares of Common Stock underlying the Units (the “Shares”), the Warrants and
NANOVIBRONIX, INC. _______ Units, each consisting of One Share of Common Stock, $0.001 par value and One Redeemable Warrant to Purchase One Share of Common Stock, $0.001 par value FORM OF UNDERWRITING AGREEMENTNanoVibronix, Inc. • May 8th, 2014 • Orthopedic, prosthetic & surgical appliances & supplies • New York
Company FiledMay 8th, 2014 Industry JurisdictionNanoVibronix, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the several underwriters (the “Underwriters”) named on Schedule I hereto for whom you are acting as representative (the “Representative”), an aggregate of [___________] units (the “Underwritten Units”) of the Company’s securities. The Company has granted the Underwriters the option to purchase an aggregate of up to ___________ additional units (the “Additional Units” and collectively with the Underwritten Units, the “Units”) as may be necessary to cover over-allotments made in connection with the offering. Each Unit consists of one share of the Company’s common stock, par value $0.001 per share (the “Common Stock”), and one redeemable warrant (each, a “Warrant” and collectively, the “Warrants”). Each Warrant entitles the holder to purchase one share of Common Stock. The Units, the shares of Common Stock underlying the Units (the “Shares”), the Wa
NANOVIBRONIX, INC. _______ Units, each consisting of One Share of Common Stock, $0.001 par value and One- Half of a Redeemable Warrant to Purchase One Share of Common Stock, $0.001 par value FORM OF UNDERWRITING AGREEMENTNanoVibronix, Inc. • May 2nd, 2014 • Orthopedic, prosthetic & surgical appliances & supplies • New York
Company FiledMay 2nd, 2014 Industry JurisdictionNanoVibronix, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the several underwriters (the “Underwriters”) named on Schedule I hereto for whom you are acting as representative (the “Representative”), an aggregate of [___________] units (the “Underwritten Units”) of the Company’s securities. The Company has granted the Underwriters the option to purchase an aggregate of up to ___________ additional units (the “Additional Units” and collectively with the Underwritten Units, the “Units”) as may be necessary to cover over-allotments made in connection with the offering. Each Unit consists of one share of the Company’s common stock, par value $0.001 per share (the “Common Stock”), and one-half of a redeemable warrant (each, a “Warrant” and collectively, the “Warrants”). Each Warrant entitles the holder to purchase one share of Common Stock. The Units, the shares of Common Stock underlying the Units (the “Shares